Skip to main content
BIP logo

February 05, 2021

Internal newsletter of the Institut Pasteur

Institut Pasteur
  • Français
  • English
News

Glioblastoma : Tunelling nanotubles could be a new therapeutic target

Cancer is the leading cause of mortality in France. In the last 40 years, survival rates have increased for several types of cancer, such as breast or prostate cancer. However, brain cancer is still an incurable disease, as it usually becomes resistant to therapy and relapses in a relatively short time. The outcome is almost inexorably the patient death. Researchers headed by Chiara Zurzolo at the Institut Pasteur have studied tunnelling nanotubes in glioblastoma, the most aggressive brain cancer. 

Find out more

 

<<< Retour
  • BIP Archives
  • Contact